NASDAQ:AADI Aadi Bioscience (AADI) Stock Price, News & Analysis $3.86 +0.04 (+1.05%) As of 09/24/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC Filings About Aadi Bioscience Stock (NASDAQ:AADI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aadi Bioscience alerts:Sign Up Key Stats Today's Range$3.75▼$3.9150-Day Range$3.66▼$5.0852-Week Range$1.21▼$3.81Volume245,788 shsAverage Volume261,100 shsMarket Capitalization$95.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Aadi Bioscience, Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers. Its work has centered on treatments that target molecular pathways involved in tumor growth, with an emphasis on rare and underserved oncology indications. The company’s principal product is FYARRO (sirolimus protein-bound particles for injectable suspension), also known as nab-sirolimus. The U.S. Food and Drug Administration approved FYARRO in 2021 for the treatment of adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor, a rare form of cancer. The therapy is designed to inhibit the mammalian target of rapamycin, or mTOR, pathway. Aadi has focused primarily on the U.S. market, where FYARRO has been commercialized for eligible oncology patients. The company was established to advance targeted cancer treatments and has concentrated its operations on oncology drug development and commercialization. Information about its current leadership and broader international operations is limited in publicly available sources.AI Generated. May Contain Errors. Read More Receive AADI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AADI Stock News HeadlinesPancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsightOctober 13, 2025 | finance.yahoo.comWhitehawk Therapeutics May 2025 slides: Pivoting to ADC development with three candidatesMay 15, 2025 | uk.investing.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 25 at 1:00 AM | Banyan Hill Publishing (Ad)Metastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsightMay 14, 2025 | finance.yahoo.comMarginal Benefits in High-Risk Ovarian Cancer With Addition of Bevacizumab to ChemoMay 13, 2025 | msn.comFYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsightApril 17, 2025 | finance.yahoo.comWhitehawk Therapeutics files to sell 41.67M shares of common stock for holdersApril 2, 2025 | markets.businessinsider.comWhitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken PharmaceuticalsMarch 26, 2025 | finance.yahoo.comSee More Headlines AADI Stock Analysis - Frequently Asked Questions How have AADI shares performed this year? Aadi Bioscience's stock was trading at $2.47 at the beginning of the year. Since then, AADI stock has increased by 56.3% and is now trading at $3.86. How were Aadi Bioscience's earnings last quarter? Aadi Bioscience, Inc. (NASDAQ:AADI) announced its quarterly earnings results on Tuesday, March, 18th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.30) by $0.37. The company earned $7.24 million during the quarter, compared to the consensus estimate of $7.45 million. Aadi Bioscience had a negative trailing twelve-month return on equity of 71.87% and a negative net margin of 246.06%. Read the conference call transcript. When did Aadi Bioscience's stock split? Aadi Bioscience's stock reverse split on Friday, August 27th 2021.The 1-15 reverse split was announced on Thursday, August 26th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 25th 2021. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Aadi Bioscience? Shares of AADI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aadi Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aadi Bioscience investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Moderna (MRNA), NVIDIA (NVDA) and Alphabet (GOOG). Company Calendar Last Earnings3/18/2025Today9/25/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:AADI CIK1422142 Webaadibio.com Phone(424) 473-8055FaxN/AEmployees40Year Founded2011Profitability EPS (Trailing Twelve Months)($2.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$65.76 million Net Margins-246.06% Pretax Margin-246.06% Return on Equity-71.87% Return on Assets-57.28% Debt Debt-to-Equity RatioN/A Current Ratio4.89 Quick Ratio4.54 Sales & Book Value Annual Sales$25.07 million Price / Sales3.80 Cash FlowN/A Price / Cash FlowN/A Book Value$4.29 per share Price / Book0.90Miscellaneous Outstanding Shares24,697,000Free Float15,485,000Market Cap$95.33 million OptionableNo Data Beta0.68 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:AADI) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
